Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Finished Goods: 2020

Historic Finished Goods for UroGen Pharma (URGN) over the last 1 years, with Dec 2020 value amounting to $913,000.

  • UroGen Pharma's Finished Goods was N/A to $888,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $888,000, marking a year-over-year change of. This contributed to the annual value of $913,000 for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, UroGen Pharma's Finished Goods is $913,000.
  • UroGen Pharma's Finished Goods' 5-year high stood at $913,000 during FY2020, with a 5-year trough of $913,000 in FY2020.
  • Its 1-year average for Finished Goods is $913,000, with a median of $913,000 in 2020.